Secondary Logo

Journal Logo

April 2016 - Volume 38 - Issue 2
pp: 143-284

Therapeutic Drug Monitoring of Everolimus: A Consensus Report

Shipkova, Maria; Hesselink, Dennis A.; Holt, David W.; More

Therapeutic Drug Monitoring. 38(2):143-169, April 2016.


Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee

Seger, Christoph; Shipkova, Maria; Christians, Uwe; More

Therapeutic Drug Monitoring. 38(2):170-189, April 2016.


A Lack of Significant Effect of POR*28 Allelic Variant on Tacrolimus Exposure in Kidney Transplant Recipients

Jannot, Anne-Sophie; Vuillemin, Xavier; Etienne, Isabelle; More

Therapeutic Drug Monitoring. 38(2):223-229, April 2016.

In Vivo Cytochrome P450 3A Isoenzyme Activity and Pharmacokinetics of Imatinib in Relation to Therapeutic Outcome in Patients With Chronic Myeloid Leukemia

Skoglund, Karin; Richter, Johan; Olsson-Strömberg, Ulla; More

Therapeutic Drug Monitoring. 38(2):230-238, April 2016.